Ipilimumab (active substance) - analogs
Pharmgroups: Antitumor agents - monoclonal antibodies |
|||||||||
| Prices in pharmacies: Instructions Ipilimumab | |||||||||
|
ⓘ✘Enter drugs for checking interactions through a quick button search . |
|
ⓘ✘ diseases to evaluate contraindications and side effects through a quick search. | ||||||
Начиная работу с сервисом, вы принимаете соглашение пользователя. Kiberis do not replace the doctor!
Ipilimumab included in the composition |
Prices in pharmacies |
| Ipilimumab |
-
Similar
Prices in
pharmaciesAnalogs by action ⓘ✘Analogues of the drug according to its degree of similarity with other drugs that are not direct analogues
- 40% Prolgolimab
- 39% Isatuximab
- 35% Pertuzumab
- 35% Elotuzumab
- 35% Avelumab
- 35% Catumaxomab
- 32% Pembrolizumab
- 32% Vemurafenib
- 32% Durvalumab
- 32% Nurulimab+Prolgolimab [Prolgolimab]
- 32% Dabrafenib
- 32% Trastuzumab emtansine
- 32% Cobimetinib
- 31% Nivolumab
- 31% Trastuzumab
- 30% Apalutamide
- 30% Vaccinum for immunotherape cancer of vesica urinaria
- 30% Hexylaminolevulinate
- 30% Darolutamide
- 30% Streptozocin
- 29% Fotemustine
- 29% Blinatumomab
- 29% Obinutuzumab
- 29% Inotuzumab ozogamicin
- 29% Binimetinib
- 29% Tremelimumab
- 28% Teclistamab
- 25% Nilotinib
- 25% Osimertinib
- 25% Enzalutamide
- 25% Ribociklib
- 25% Daratumumab
- 25% Abiraterone
- 25% Gefitinib
- 25% Ceritinib
- 25% Aldesleukin
- 25% Ixabepilone
- 25% Afatinib
- 25% Nilutamide
- 25% Capmatinib
- 25% Drostanolone
- 24% Lapatinib
- 24% Larotrectinib
- 24% Panitumumab
- 24% Camrelizumab
- 23% Trastuzumab deruxtecan
- 22% Palbociclib
- 22% Axitinib
- 22% Atezolizumab
- 22% Talazoparib
Learn more about the selection of analogues
▶
- The drug has «Ipilimumab» 51 analog by action, the most similar - Prolgolimab .
- Medical online service has selected the best substitutes for Ipilimumab based on its instructions, components, pharmaceutical groups and practical application.
- The table shows the prices of analogues Ipilimumab to choose the cheapest pills.
- If you have introduced other drugs for registration, substitutes are selected taking into account the assessment of interactions and safety.
- Sometimes, due to the presence of dangerous interactions, it is necessary to use drugs that are similar in effect, sometimes even from different pharmacological groups.